Skip to main content

Table 1 Genomic TNBC subtypes and assignment of TNBC cell lines to subtypes

From: Triple-negative breast cancer molecular subtyping and treatment progress

TNBC subtype

Genetic abnormalities

Cell line

Subtype correlationA (p value)

Histology

Mutations

Basal-like 1

Cell cycle gene expression

DNA repair gene (ATR-BRCA pathway)

Proliferation genes

HCC2157

HCC1599

HCC1937

HCC1143

HCC3153

MDA-MB-468

HCC38

0.66 (0.00)

0.62 (0.00)

0.28 (0.00)

0.26 (0.00)

0.24 (0.00)

0.19 (0.06)

0.19 (0.01)

DC

DC

DC

IDC

DC

DC

BRCA1; STAT4; UTX

BRCA2; TP53; CTNND1; TOP2B; CAMK1G

BRCA1; TP53; MAPK13; MDC1

TP53

BRCA1

PTEN; RB1; SMAD4; TP53

CDKN2A; TP53

Basal-like 2

Growth factor-signaling pathways (EGFR, MET, NGF, Wnt/β-catenin, IGF-1R)

Glycolysis, gluconeogenesis

Expression of myoepithelial markers

SUM149PT

CAL-851

HCC70

HCC1806

HDQ-P1

0.30 (0.00)

0.25 (0.00)

0.24 (0.04)

0.22 (0.00)

0.18 (0.17)

INF

IGA

DC

ASCC

IDC

BRCA1

RB1; TP53

PTEN; TP53

CDKN2A; TP53; UTX

TP53

Immunomodulatory

Immune cell processes (CTLA4, IL2, IL7 pathways, antigen processing/presentation) Gene signature for medullary BC (rare TNBC with a favorable prognosis)

HCC1187

DU4475

0.22 (0.00)

0.17 (0.00)

DC

DC

TP53; CTNNA1; DDX18; HUWE1; NFKBIA

APC; BRAF; MAP 2 K4; RB1

Mesenchymal-like

Cell motility

Cell differentiation

Growth factor signaling

EMT

BT-549

CAL-51

CAL-120

0.21 (0.00)

0.17 (0.00)

0.09 (0.00)

IDC

AC

AC

PTEN; RB1; TP53

PIK3CA

TP53

Mesenchymal stem-like

Similar to M+

Low proliferation

Angiogenesis genes

HS578T

MDA-MB-157

SUM159PT

MDA-MB-436

MDA-MB-231

0.29 (0.00)

0.25 (0.00)

0.14 (0.00)

0.13 (0.00)

0.12 (0.00)

CS

MBC

ANC

IDC

IDC

CDKN2A; HRAS; TP53

NF1; TP53

PIK3CA; TP53 HRAS

BRCA1; TP53

BRAF; CDKN2A; KRAS; NF2; TP53; PDGFRA

Luminal androgen receptor

Androgen receptor gene

Luminal gene expression pattern

Molecular apocrine subtype

MDA-MB-453

SUM185PE

HCC2185

CAL-148

MFM-223

0.53 (0.00)

0.39 (0.00)

0.34 (0.00)

0.32(0.00)

0.31 (0.00)

AC

DC

AC

AC

PIK3CA; CDH1; PTEN

PIK3CA

PIK3CA

PIK3CA; RB1; TP53; PTEN

PIK3CA; TP53

  1. Data from Lehmann et al. [14]
  2. Abbreviations: AC adenocarcinoma, ANC anaplastic carcinoma, ASCC acantholytic squamous cell carcinoma, CS carcinosarcoma, DC ductal carcinoma, IDC invasive ductal carcinoma, IGA invasive galactophoric adenocarcinoma, INF inflammatory ductal carcinoma, MC metaplastic carcinoma and MBC medullary breast cancer
  3. AGene expression (GE) data for TNBC cell lines (GSE-10890 and E-TABM-157) were correlated (Spearman) to the centroids of the GE signatures for each TNBC subtype. GE data from both the TNBC tumors and cell lines were combined so that each gene was standardized to have mean = 0 and SD = 1. GE profiles from the cell lines were correlated to the centroids for each of the 6 TNBC subtypes. Cell lines were assigned to the TNBC subtype with the highest correlation, and those that had low correlations (< 0.1) or were similar between multiple subtypes (p > 0.05) were considered unclassified